/stocks — the workspaceLOADING
What the company’s own results press releases said it expected, in its words, and what it later filed for the same period. Earnings per share and revenue stated as amounts; guidance given as a growth rate is not read. Back to ABT earnings
Read from 2 results releases filed 2026-07-16 to 2026-10-21; updated 2026-11-08.
- Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58
• Abbott reaffirms the midpoint of previously provided full-year 2026 adjusted diluted EPS guidance range and tightens the range to $5.50 to $5.55.
Not paired: a full-year or fourth-quarter adjusted figure would come from the fourth-quarter release, and this register does not match that release to a period.
Abbott projects fourth-quarter 2026 adjusted diluted earnings per share of $1.62 to $1.67.
Not paired: a full-year or fourth-quarter adjusted figure would come from the fourth-quarter release, and this register does not match that release to a period.
Abbott projects third-quarter 2026 adjusted diluted earnings per share of $1.38 to $1.46 .
Not paired: the release filed 2026-10-21 reports this quarter, but we read no adjusted figure from it.
How this is read: a guidance figure is kept only when its sentence or table row names the measure, the period and an amount, and a revision’s current range is the one its own words mark as current. Measured 2026-11-05 on 71 results releases read by hand: it printed 56 guidance items, all of them right, and left out 19 of the 75 the documents state, because its rules abstain rather than guess. GAAP figures and revenue are paired with the company’s XBRL; an adjusted figure with the release whose 10-Q names the same quarter. This is what the company said and filed, not a forecast of ours, and nothing here is a recommendation to buy, sell or hold ABT.